1. Home
  2. VINC vs STRR Comparison

VINC vs STRR Comparison

Compare VINC & STRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VINC
  • STRR
  • Stock Information
  • Founded
  • VINC 2019
  • STRR 1985
  • Country
  • VINC United States
  • STRR United States
  • Employees
  • VINC N/A
  • STRR N/A
  • Industry
  • VINC Biotechnology: Pharmaceutical Preparations
  • STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • VINC Health Care
  • STRR Health Care
  • Exchange
  • VINC Nasdaq
  • STRR Nasdaq
  • Market Cap
  • VINC 6.2M
  • STRR 7.0M
  • IPO Year
  • VINC N/A
  • STRR N/A
  • Fundamental
  • Price
  • VINC $0.15
  • STRR $2.29
  • Analyst Decision
  • VINC Buy
  • STRR
  • Analyst Count
  • VINC 2
  • STRR 0
  • Target Price
  • VINC $2.00
  • STRR N/A
  • AVG Volume (30 Days)
  • VINC 21.3M
  • STRR 25.4K
  • Earning Date
  • VINC 11-12-2024
  • STRR 11-19-2024
  • Dividend Yield
  • VINC N/A
  • STRR N/A
  • EPS Growth
  • VINC N/A
  • STRR N/A
  • EPS
  • VINC N/A
  • STRR N/A
  • Revenue
  • VINC N/A
  • STRR $50,375,000.00
  • Revenue This Year
  • VINC N/A
  • STRR $15.58
  • Revenue Next Year
  • VINC N/A
  • STRR $36.27
  • P/E Ratio
  • VINC N/A
  • STRR N/A
  • Revenue Growth
  • VINC N/A
  • STRR 2.22
  • 52 Week Low
  • VINC $0.14
  • STRR $2.06
  • 52 Week High
  • VINC $9.37
  • STRR $5.35
  • Technical
  • Relative Strength Index (RSI)
  • VINC 37.12
  • STRR 45.36
  • Support Level
  • VINC $0.14
  • STRR $2.10
  • Resistance Level
  • VINC $0.52
  • STRR $2.39
  • Average True Range (ATR)
  • VINC 0.04
  • STRR 0.12
  • MACD
  • VINC -0.00
  • STRR 0.04
  • Stochastic Oscillator
  • VINC 3.25
  • STRR 66.67

About VINC Vincerx Pharma Inc.

Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are conducted in the United States. It focuses on developing, using, manufacturing, commercializing, sublicensing, and distributing a clinical-stage and follow-on small molecule drug program and a preclinical-stage bioconjugation/next-generation ADC platform.

About STRR Star Equity Holdings Inc.

Star Equity Holdings Inc is a multi-industry diversified holding company with two segments: The construction segment manufactures modular housing units for commercial and residential applications. It operates in two businesses: modular building manufacturing and structural wall panel and wood foundation manufacturing, including building supply retail operations, and The investments segment holds corporate-owned real estate, which currently includes two manufacturing facilities in Maine that it leases back to KBS and manufacturing facility. The company derives maximum revenue from Construction Segment.

Share on Social Networks: